Form 4: MicroStrategy Executive Wei-Ming Shao Reports Stock Option Exercise and Sale
SEC Form 4 Filing
MicroStrategy's SEVP & General Counsel, Wei-Ming Shao, exercised stock options and sold shares of Class A Common Stock on February 27, 2024.
Summary
- On February 27, 2024, Wei-Ming Shao, SEVP & General Counsel of MicroStrategy, exercised stock options to acquire 3,000 shares of Class A Common Stock at a price of $151.60.
- Simultaneously, Mr. Shao sold 3,000 shares of Class A Common Stock at a price of $852.74.
- Following these transactions, Mr. Shao directly owns 3,453 shares of Class A Common Stock.
- Mr. Shao also holds various employee stock options and restricted stock units (RSUs) with future vesting dates.
Sentiment
Score: 5
Explanation: Neutral sentiment. This is a standard SEC filing reporting insider transactions. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Future Outlook
The document details future vesting schedules for stock options and restricted stock units held by Mr. Shao, indicating continued equity-based compensation.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings to gauge executive sentiment and potential future actions.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- Vesting schedules are typical, designed to incentivize long-term performance and retention.
- The specific terms of Mr. Shao's options and RSUs (exercise prices, vesting dates) are likely benchmarked against industry standards for executive compensation at similarly sized technology companies.
- Companies like Palantir, Snowflake, and Datadog also utilize stock options and RSUs as part of their executive compensation packages.
Stakeholder Impact
- Shareholders may be interested in insider transactions as an indicator of executive confidence.
- The transactions have a minimal direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| February 23, 2022 | 5,000 shares of Class A common stock vested under an employee stock option with an exercise price of $691.23 per share and an expiration date of February 23, 2031. |
| November 22, 2022 | Shares vested under an employee stock option (Right to buy). |
| February 17, 2023 | 5,000 shares of Class A common stock vested under an employee stock option with an exercise price of $404.60 per share and an expiration date of February 17, 2032. |
| February 23, 2023 | 5,000 shares of Class A common stock vested under an employee stock option with an exercise price of $691.23 per share and an expiration date of February 23, 2031. |
| November 10, 2023 | 5,000 shares of Class A common stock vested under an employee stock option with an exercise price of $175.00 per share and an expiration date of November 10, 2032. |
| November 22, 2023 | Shares vested under an employee stock option (Right to buy). |
| February 17, 2024 | 5,000 shares of Class A common stock vested under an employee stock option with an exercise price of $404.60 per share and an expiration date of February 17, 2032. |
| February 23, 2024 | 5,000 shares of Class A common stock vested under an employee stock option with an exercise price of $691.23 per share and an expiration date of February 23, 2031. |
| February 27, 2024 | Wei-Ming Shao exercised stock options and sold shares of Class A Common Stock. |
| February 28, 2024 | Date of signature for the report. |
| June 5, 2024 | 383 shares are scheduled to vest under restricted stock units. |
| November 10, 2024 | 5,000 shares are scheduled to vest under an employee stock option with an exercise price of $175.00 per share and an expiration date of November 10, 2032. |
| November 13, 2024 | 250 shares are scheduled to vest under restricted stock units. |
| February 23, 2025 | 5,000 shares are scheduled to vest under an employee stock option with an exercise price of $691.23 per share and an expiration date of February 23, 2031. |
| February 17, 2025 | 5,000 shares are scheduled to vest under an employee stock option with an exercise price of $404.60 per share and an expiration date of February 17, 2032. |
| June 5, 2025 | 383 shares are scheduled to vest under restricted stock units. |
| November 10, 2025 | 5,000 shares are scheduled to vest under an employee stock option with an exercise price of $175.00 per share and an expiration date of November 10, 2032. |
| February 17, 2026 | 5,000 shares are scheduled to vest under an employee stock option with an exercise price of $404.60 per share and an expiration date of February 17, 2032. |
| June 5, 2026 | 383 shares are scheduled to vest under restricted stock units. |
| May 31, 2026 | End of the three-year performance period for performance stock units (PSUs) granted on June 5, 2023. |
| November 10, 2026 | 5,000 shares are scheduled to vest under an employee stock option with an exercise price of $175.00 per share and an expiration date of November 10, 2032. |
| June 5, 2027 | 384 shares are scheduled to vest under restricted stock units. |
| November 22, 2029 | Expiration date of an employee stock option (Right to buy). |
| February 23, 2031 | Expiration date of an employee stock option with an exercise price of $691.23 per share. |
| February 17, 2032 | Expiration date of an employee stock option with an exercise price of $404.60 per share. |
| November 10, 2032 | Expiration date of an employee stock option with an exercise price of $175.00 per share. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.